Nant Capital

Nant Capital is a private investment firm specializing in biotechnology and media investments. Founded by Dr. Patrick Soon-Shiong, the firm focuses on sectors such as biotechnology, media, healthcare, and technology. Nant Capital employs a strategic approach to investing, targeting early-stage to pre-IPO companies with high growth potential. The firm is known for its disciplined investment philosophy, emphasizing long-term value creation and portfolio diversification. Nant Capital has a track record of successful investments in various industries, demonstrating its commitment to fostering innovation and supporting the growth of emerging companies.

The firm's investment strategy includes a focus on private equity, venture capital, and real estate, with investments ranging from $1 million to $50 million. Nant Capital's geographical focus is primarily on the United States, reflecting its commitment to supporting domestic innovation and economic growth. The firm has a diverse portfolio, encompassing industries such as biotechnology, media, healthcare, technology, pharmaceuticals, medical devices, diagnostics, digital health, telemedicine, artificial intelligence, data analytics, software, e-commerce, consumer goods, and retail.

Nant Capital's leadership, under the guidance of Dr. Patrick Soon-Shiong, leverages extensive experience in both the biotechnology and media sectors. This expertise enables the firm to identify and capitalize on investment opportunities that align with its strategic objectives. The firm's approach is characterized by a thorough due diligence process, a commitment to fostering innovation, and a focus on creating value for its stakeholders. Nant Capital's investments aim to drive growth and deliver sustainable returns, reflecting its dedication to excellence and its role as a catalyst for progress in the industries it serves.